Eli Lilly and Comp. (LLY) stock forecast for 2022

The forecast has been updated: January 13, 2022 8:59


Eli Lilly and Comp. stock price online today

Analyst Target Price

278.94

Dividend Date

10.03.2022

Ex Dividend Date

14.02.2022

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell Eli Lilly and Comp. stock stock today? What is the projected target price level for 2022? How much will it cost in 2022? Eli Lilly and Comp. stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2022.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $278.94 target price for Eli Lilly and Comp. stock stock.

Today 200 Day Moving Average is the support level (232.12 $).

50 Day Moving Average is the support level (259.44 $).




LLY Forecast for 2022

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Feb 256.86 243.84 268.22 9.09 %
Mar 257.87 233.39 264.91 11.90 %
Apr 261.89 243.84 275.51 11.49 %
May 230.23 217.66 242.80 10.35 %
Jun 244.29 236.35 250.64 5.70 %
Jul 249.37 233.49 266.23 12.30 %
Aug 252.94 227.29 273.99 17.04 %
Sep 256.23 229.91 267.89 14.18 %
Oct 253.56 233.79 274.66 14.88 %
Nov 249.61 224.62 271.35 17.22 %
Dec 228.19 205.05 240.35 14.69 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Eli Lilly and Comp. stock.


Eli Lilly and Comp. overview

Eli Lilly and Comp. Address

LILLY CORPORATE CTR, DROP CODE 1112, INDIANAPOLIS, IN, US

Market Capitalization

259 934 800 000 $

EBITDA

9 657 000 000

PE Ratio

35.59

PEG Ratio

1.742

Dividend Per Share

3.29

Dividend Yield

0.0142

EPS

6.55

Quarterly Earnings Growth YOY

-0.083

Quarterly Revenue Growth YOY

0.18

Trailing PE

40.73

Forward PE

28.74

EV To Revenue

8.89

EV To EBITDA

28.69

52 Week High

283.9

52 Week Low

159.37

50 Day Moving Average

259.44

200 Day Moving Average

232.12

Shares Outstanding

956592000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

Eli Lilly and Comp. stock forecast for this year


Eli Lilly and Comp. stock forecast for Feb 2022.
Estimated Average Forecasted Eli Lilly and Comp. Price: 256.86. Positive monthly dynamics of the instrument is expected with 9.088% volatility is expected.

Pessimistic forecast: 243.84

Optimistic: 268.22


Eli Lilly and Comp. stock forecast for Mar 2022.
Estimated Average Forecasted Eli Lilly and Comp. Price: 257.87. Positive monthly dynamics of the instrument is expected with 11.895% volatility is expected.

Pessimistic forecast: 233.39

Optimistic: 264.91


Eli Lilly and Comp. stock forecast for Apr 2022.
Estimated Average Forecasted Eli Lilly and Comp. Price: 261.89. Positive monthly dynamics of the instrument is expected with 11.492% volatility is expected.

Pessimistic forecast: 243.84

Optimistic: 275.51


Eli Lilly and Comp. stock forecast for May 2022.
Estimated Average Forecasted Eli Lilly and Comp. Price: 230.23. Negative monthly dynamics of the instrument is expected with 10.354% volatility is expected.

Pessimistic forecast: 217.66

Optimistic: 242.80


Eli Lilly and Comp. stock forecast for Jun 2022.
Estimated Average Forecasted Eli Lilly and Comp. Price: 244.29. Positive monthly dynamics of the instrument is expected with 5.702% volatility is expected.

Pessimistic forecast: 236.35

Optimistic: 250.64


Eli Lilly and Comp. stock forecast for Jul 2022.
Estimated Average Forecasted Eli Lilly and Comp. Price: 249.37. Positive monthly dynamics of the instrument is expected with 12.299% volatility is expected.

Pessimistic forecast: 233.49

Optimistic: 266.23


Eli Lilly and Comp. stock forecast for Aug 2022.
Estimated Average Forecasted Eli Lilly and Comp. Price: 252.94. Positive monthly dynamics of the instrument is expected with 17.042% volatility is expected.

Pessimistic forecast: 227.29

Optimistic: 273.99


Eli Lilly and Comp. stock forecast for Sep 2022.
Estimated Average Forecasted Eli Lilly and Comp. Price: 256.23. Positive monthly dynamics of the instrument is expected with 14.175% volatility is expected.

Pessimistic forecast: 229.91

Optimistic: 267.89


Eli Lilly and Comp. stock forecast for Oct 2022.
Estimated Average Forecasted Eli Lilly and Comp. Price: 253.56. Negative monthly dynamics of the instrument is expected with 14.882% volatility is expected.

Pessimistic forecast: 233.79

Optimistic: 274.66


Eli Lilly and Comp. stock forecast for Nov 2022.
Estimated Average Forecasted Eli Lilly and Comp. Price: 249.61. Negative monthly dynamics of the instrument is expected with 17.220% volatility is expected.

Pessimistic forecast: 224.62

Optimistic: 271.35


Eli Lilly and Comp. stock forecast for Dec 2022.
Estimated Average Forecasted Eli Lilly and Comp. Price: 228.19. Negative monthly dynamics of the instrument is expected with 14.687% volatility is expected.

Pessimistic forecast: 205.05

Optimistic: 240.35



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 128.16 (14.01.2022) -1.15 %
AbbVie Inc.
ABBV 135.87 (14.01.2022) 1.76 %
Aeterna Zentaris Inc.
AEZS 0.3597 (14.01.2022) 0.14 %
Allakos Inc.
ALLK 7.64 (14.01.2022) -2.68 %
Allogene Therapeutics, Inc.
ALLO 13.28 (14.01.2022) 11.04 %
Amgen Inc.
AMGN 235.36 (14.01.2022) 1.95 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 16.07 (14.01.2022) 12.93 %
Aurora Cannabis Inc.
ACB 5.51 (14.01.2022) -0.54 %
Becton Dickinson and Company
BDX 262.62 (14.01.2022) -0.41 %
Biogen Inc.
BIIB 239.3 (14.01.2022) 1.11 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 122.17 (14.01.2022) -0.46 %
BioNTech SE
BNTX 196 (14.01.2022) -3.44 %
bluebird bio, Inc.
BLUE 8.73 (14.01.2022) 2.46 %
Boston Scientific Corp.
BSX 44.86 (14.01.2022) 0.65 %
Bristol-Myers Squibb Company
BMY 64.93 (14.01.2022) 0.51 %
Canopy Growth Corp.
CGC 8.4 (14.01.2022) -0.12 %
Castle Biosciences, Inc.
CSTL 36.69 (14.01.2022) -0.73 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 244.12 (14.01.2022) -2.22 %
Emergent BioSolutions Inc.
EBS 52.22 (14.01.2022) 5.54 %
Exelixis, Inc.
EXEL 18.12 (14.01.2022) 1.97 %
G1 Therapeutics, Inc.
GTHX 10.11 (14.01.2022) 6.42 %
Gilead Sciences, Inc.
GILD 71.77 (14.01.2022) -0.15 %
GlaxoSmithKline plc
GSK 45.47 (14.01.2022) 0.91 %
GoodRx Holdings, Inc.
GDRX 26.85 (14.01.2022) -1.32 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 74.88 (14.01.2022) 1.67 %
Inovio Pharmaceuticals, Inc.
INO 4.275 (18.01.2022) -10.00 %
Johnson & Johnson
JNJ 167.84 (14.01.2022) -0.55 %
Medtronic plc.
MDT 108.55 (14.01.2022) -0.21 %
Merck & Co., Inc.
MRK 81.38 (14.01.2022) 0.07 %
Moderna, Inc.
MRNA 204.73 (14.01.2022) -2.59 %
Novartis AG
NVS 90.55 (14.01.2022) -0.08 %
Novavax, Inc.
NVAX 110.82 (14.01.2022) -1.39 %
ObsEva SA
OBSV 1.92 (14.01.2022) 1.59 %
OrganiGram Holdings Inc.
OGI 1.64 (14.01.2022) -1.20 %
Pfizer Inc.
PFE 54.95 (14.01.2022) -1.06 %
Regeneron Pharmaceuticals, Inc.
REGN 615.24 (14.01.2022) -0.14 %
Sanofi
SNY 51.93 (14.01.2022) 2.37 %
Schrodinger, Inc.
SDGR 30.69 (14.01.2022) 3.40 %
Senseonics Holdings, Inc.
SENS 2.84 (14.01.2022) 2.16 %
Sorrento Therapeutics, Inc.
SRNE 4.56 (14.01.2022) 5.31 %
Stryker Corp.
SYK 266.71 (14.01.2022) -0.44 %
Sundial Growers Inc.
SNDL 0.564 (14.01.2022) 0.64 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 9.17 (14.01.2022) -0.33 %
Thermo Fisher Scientific Inc.
TMO 594.8 (14.01.2022) -1.01 %
Tilray, Inc.
TLRY 6.86 (14.01.2022) -0.15 %
UnitedHealth Group, Inc.
UNH 468.69 (14.01.2022) 0.27 %
Veeva Systems Inc.
VEEV 223.85 (14.01.2022) -1.45 %
Zomedica Corp.
ZOM 0.35 (14.01.2022) 4.45 %
Zynerba Pharmaceuticals, Inc.
ZYNE 2.63 (14.01.2022) 3.14 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.